In this study, we envisage that chemotherapy-induced ICD can be combined with other immunotherapy methods, such as inhibition of CD47 expression, a combination of R848, to regulate the immune microenvironment, enhance tumor immunogenicity, and inhibit tumor growth, recurrence, and metastasis. This evidence concerns the gene CD47 and neoplasm.